Rallybio (RLYB) Stock Price, Quote, News & History | Benzinga

Rallybio Corp (RLYB) Stock Price, Quote, News & History

RLYBNASDAQ

Trade with Public

Trade with Public

$16.98

0.0950.56%

Last update: Aug 27, 12:36 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$17.18

Close

-

Volume / Avg.

1.85K / 44.03K

Day Range

$16.83 - $17.23

52 Wk Range

3.67 - 17.57

Market Cap

$90.08M

P/E Ratio

2.13

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

1.24%

Days to Cover

2.02

Recent Rallybio Corp News

Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, valuing GME at $55.5B. eBay shares jumped 8.1% to $112.50 in pre-market trading.

Avi Kapoor

Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism

Rallybio stock jumps after announcing a $505 million merger with Candid Therapeutics, boosting cash to $700 million.

Vandana Singh

Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026

Rallybio reports strong Phase 1 results for RLYB116, showing full immune pathway control with good safety and Phase 2 plans ahead.

Vandana Singh

Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.

Vandana Singh

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

26.71M

Investing Cash Flow (TTM)

56.55M

Financing Cash Flow (TTM)

140.00K

Free Cash Flow (TTM)

26.71M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

83.40M

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$2.62M

PE Ratio (TTM)

2.13

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

149.28

PB Ratio (TTM)

0.95

Earnings Yield % (TTM)

47.03%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

3.61

Book Value / Share

$17.79

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$92.85M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$17.18

Close

-

Volume / Avg.

1.85K / 44.03K

Day Range

$16.83 - $17.23

52 Wk Range

3.67 - 17.57

Market Cap

$90.08M

P/E Ratio

2.13

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

1.24%

Days to Cover

2.02

About

Sector

Health Care

Industry

Biotechnology

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for p...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ:RLYB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Rallybio (RLYB) competitors?

A

Other companies in Rallybio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Moderna Inc (NASDAQ:MRNA) and Natera Inc (NASDAQ:NTRA).

Q

What is the forecast, or price target, for Rallybio (RLYB) stock?

A

Rallybio has a consensus price target of $8.88.

Q

What is the current price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $16.975 last updated August 27, 2026 at 12:36 PM EDT.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio does not have any upcoming earnings scheduled.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.